Corresponding author:Denis Landaverde, Medical Oncologist, Department of Hematology and Oncology, Hospital Mexico, University of Costa Rica, Mexico
Received: July 22, 2017; Published: August 07, 2017
To view the Full Article Peer-reviewed Article PDF
Alveolar soft-part sarcoma is a rare malignant entity with poor prognosis. Chemotherapy has limited activity in this type of sarcoma, we describe here the outcomes of the first case documented in our Institution with metastatic disease, treated exclusively with sunitinib.